Literature DB >> 8390812

Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

N Lachance1, C Gaudreau, F Lamothe, F Turgeon.   

Abstract

The percentages of susceptibility of 28 strains of Campylobacter coli to beta-lactam agents were 96% for amoxicillin and ampicillin, 57% for ticarcillin, 4% for cefoxitin and cefuroxime, 61% for cefotaxime, and 11% for ceftazidime. None of the strains were susceptible to penicillin G, piperacillin, cefazolin, cephalothin, cefamandole, and cefoperazone. All strains were susceptible to imipenem and ciprofloxacin, and 21% were susceptible to erythromycin. A beta-lactamase was detected in 68% of the strains by cefinase disks and by the nitrocefin method. The beta-lactamase-positive strains were significantly less susceptible to amoxicillin, ampicillin, and ticarcillin than the beta-lactamase-negative strains (P < or = 0.003). Clavulanic acid (0.25 microgram/ml) but not sulbactam and tazobactam (2 micrograms/ml) lowered to susceptible levels the amoxicillin and ampicillin MICs of the only strain of C. coli resistant to amoxicillin, ampicillin, and ticarcillin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390812      PMCID: PMC187926          DOI: 10.1128/AAC.37.5.1174

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Erythromycin resistance only found in Campylobacter coli.

Authors:  D A Secker
Journal:  J Antimicrob Chemother       Date:  1983-10       Impact factor: 5.790

2.  Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.

Authors:  H Sagara; A Mochizuki; N Okamura; R Nakaya
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

3.  Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.

Authors:  C L Gaudreau; L A Lariviere; J C Lauzer; F F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.

Authors:  W L Wang; L B Reller; M J Blaser
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

5.  Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; L A Larivière
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.

Authors:  R M Fliegelman; R M Petrak; L J Goodman; J Segreti; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

7.  Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Authors:  H Goossens; P De Mol; H Coignau; J Levy; O Grados; G Ghysels; H Innocent; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Characterization of anaerobic gram-negative bacilli by using rapid slide tests for beta-lactamase production.

Authors:  A M Bourgault; J E Rosenblatt
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

9.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report.

Authors:  E Sjögren; B Kaijser; M Werner
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Erythromycin-resistant Campylobacter infections in Thailand.

Authors:  D N Taylor; M J Blaser; P Echeverria; C Pitarangsi; L Bodhidatta; W L Wang
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

View more
  12 in total

1.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

4.  Bacteremia caused by Arcobacter cryaerophilus 1B.

Authors:  P R Hsueh; L J Teng; P C Yang; S K Wang; S C Chang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

5.  Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona.

Authors:  G Prats; B Mirelis; T Llovet; C Muñoz; E Miró; F Navarro
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

6.  Indwelling device-related bacteremia caused by serum-susceptible Campylobacter coli.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

7.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.

Authors:  P Tajada; J L Gomez-Graces; J I Alós; D Balas; R Cogollos
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni.

Authors:  Christiane Gaudreau; Yves Girouard; Huguette Gilbert; Josée Gagnon; Sadjia Bekal
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

9.  Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.

Authors:  Deborah J Griggs; Leanne Peake; Margaret M Johnson; Saba Ghori; A Mott; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

10.  Purulent pleurisy caused by Campylobacter lari.

Authors:  B Bruneau; L Burc; C Bizet; N Lambert-Zechovsky; C Branger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.